Logo
SearchSearch
Languages
Language
LoginSign up
Invest in Alnylam Pharmaceuticals Inc
Today
Create an eToro account to buy ALNY stock on a secure, user-friendly, multi-asset trading platform.
Buy Alnylam Pharmaceuticals Inc
Buy Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc ALNY
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Moderate Buy
Price Target
325.5
Based on analysts who covered ALNY
Stocks-ALNY-Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals Inc ALNY

$244.495.75(2.41%)(1D)
Nasdaqin USD

ALNY Stock Price Chart

‎-7.34‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The Alnylam Pharmaceuticals Inc share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Alnylam Pharmaceuticals Inc share price today is $244.49, reflecting a ‎2.41‎% change over the last 24 hours and ‎-1.03‎% over the past week. The current market capitalization of ALNY is 30.91B with an average volume in the last three months of 694410.8. The stock has a P/E ratio of -109.9 and a dividend yield of 0%. With the stock’s beta sitting at 0.96
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$30.91B

Day’s Range
i
Shows the high and low prices of the day.
229.66 - 254.76

52W Range
i
Shows the high and low prices of the last year.
142.71 - 303.31

Average Volume (3M)
i
The average number of shares traded per day over the last three months.
694410.8

Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-109.9

Revenue
i
The total income generated by this company’s goods and services last year.
$2.25B

Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)

Prev Close
i
The final price of this asset at the end of the last trading day.
$238.74

EPS
i
A company’s total earnings divided by the number of shares it has issued.
-2.17

Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
0.96

What Is Alnylam Pharmaceuticals Inc?
Alnylam Pharmaceuticals Inc is a speciality biopharmaceutical company based in Cambridge, Massachusetts. The firm was founded by a group of dedicated scientists and was incorporated in Delaware in 2002. It has offices around the globe, including the UK, Germany, Italy, Sweden, Japan and Brazil. The focus of Alnylam’s research is the science of RNAi (RNA interference) and to transform the lives of patients suffering from chronic diseases.

The company went public in May 2004 and is traded on the NASDAQ, under the ticker ALNY. As of August 2020, the ALNY stock chart showed a 52-week high of $167.33 and a 52-week low of $73.32. In 2020, the firm employed over 1,400 full-time members of staff. Alnylam revenue for the 12 months ending the 30th June 2020 showed a year-over-year increase of 241.39%.

Alnylam Pharmaceuticals continues to grow and innovate with a strong focus on research and development. The company focuses on continual innovation in order to improve the lives of individuals living with diseases which only have limited treatment options.

Diversify your investments today with this medical innovator, and add ALNY stock to your eToro portfolio.

How can I buy Alnylam Pharmaceuticals Inc stocks?

To purchase Alnylam Pharmaceuticals Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Alnylam Pharmaceuticals Inc (ALNY) page and place an order to buy Alnylam Pharmaceuticals Inc.
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Graph
Buy Alnylam Pharmaceuticals Inc
Invest in Alnylam Pharmaceuticals Inc
Today
Create an eToro account to buy ALNY stock on a secure, user-friendly, multi-asset trading platform.

FAQ

The current price of ALNY is $244.49.
The average price target for Alnylam Pharmaceuticals Inc is $244.49. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Alnylam Pharmaceuticals Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Alnylam Pharmaceuticals Inc is $30.91B
Scroll to top